Taher, Salama D.

HRN: 02-81-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFTRIAXONE 1G (VIAL)
06/02/2022
06/08/2022
IV
2 G
OD
CAP-MR
Waiting Final Action 
06/02/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/02/2022
06/06/2022
PO
500 Mg
OD
CAP-MR
Waiting Final Action 
06/03/2022
CEFTRIAXONE 1G (VIAL)
06/03/2022
06/07/2022
IV
2gm
OD
CAP MR
Waiting Final Action 
06/03/2022
CEFTRIAXONE 1G (VIAL)
06/03/2022
06/08/2022
IV
1gm
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: